The gross non-performing asset (GNPA) ratio was 2.43% in the September quarter, compared to 1.96% in the June quarter.

Muthoot Microfin’s net profit for the second quarter fell 44% year on year to ₹61.6 Crore, owing mostly to stress in the ...

The Board of Directors of Max Healthcare Institute Limited, at its meeting held today have approved the financial results of the company for the period ended September 30, 2024 - Q2 FY2024-25, H1 ...

Get Rs 5 Lakh Health Cover: How Senior Citizens Can Enroll For Ayushman Bharat Vaya Vandana Card IRCTC Q2 Results: Railway ...

Dr. Reddy's Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While ...

Dr. Reddy's' US sales continued to struggle due to inventory adjustments and pricing pressures on key products, Citi said.

The brokerage expects the new business avenues to take a few years before they start contributing profitably to the ...

Dr Reddy’s Laboratories posted a mixed performance in Q2FY25, reporting record revenue of Rs 8,038.2 crore, marking a strong ...

Shares of Dr. Reddy's Laboratories Ltd. will be closely watched in Wednesday's trading as its revenue for the September ...

Dr Reddy's revenue surged by 17 percent to an all-time high of ... Despite this, it reported a 15 percent on year drop in its ...

New Delhi: Pharma major Dr Reddy’s Laboratories (DRL ... Its total operating expenses grew 34.3 per cent to Rs3,021.8 crore ...

Chennai: Pharma market reported better revenue growth in Q2 FY25 against the year-ago quarter, mainly driven by price rise ...